The concerns stem from a rule established under the Biden administration, which mandates chemical plants to monitor and mitigate emissions of certain toxic substances. Industry representatives argue that adhering to the new standards could impose costs exceeding $50 billion on corporations—far surpassing the EPA's initial estimate of $1.8 billion.
In light of these challenges, the groups are appealing for a presidential waiver citing excessive financial burdens and an impractical timeline for compliance. They refer to provisions within the Clean Air Act, which allow the president to grant temporary exemptions for industrial facilities under specific conditions, particularly if compliance technology is unavailable or it poses a threat to national security.
In light of these challenges, the groups are appealing for a presidential waiver citing excessive financial burdens and an impractical timeline for compliance. They refer to provisions within the Clean Air Act, which allow the president to grant temporary exemptions for industrial facilities under specific conditions, particularly if compliance technology is unavailable or it poses a threat to national security.
